Publication
Entry inhibitors and Carbosilane dendrimers are potent inhibitors of cell-associated HIV-2 infection
dc.contributor.author | Diniz, A. R. | |
dc.contributor.author | Briz, V. | |
dc.contributor.author | Borrego, P. | |
dc.contributor.author | Palladino, C. | |
dc.contributor.author | Rodés, C. | |
dc.contributor.author | De la Mata, F. J. | |
dc.contributor.author | Gómez, R. | |
dc.contributor.author | Muñoz-Fernández, M. A. | |
dc.contributor.author | Taveira, N. | |
dc.date.accessioned | 2016-10-12T14:07:14Z | |
dc.date.available | 2016-10-12T14:07:14Z | |
dc.date.issued | 2015-03-22 | |
dc.description | Poster presented at the 2015 Keystone Symposia Conference X5: HIV Vaccines. Banff, Alberta, Canada, 22-27 March 2015 | pt_PT |
dc.description.abstract | "Pre-exposure prophylaxis with topical microbicides formulated with antiviral agents can prevent HIV-1 acquisition. The ideal microbicide should prevent both cell-free and cell-associated HIV-1 and HIV-2 infections in the vaginal or rectum mucosa. So far, few candidate microbicides have been tested against HIV-2. Previously, we have shown that anionic carbosilane dendrimers 2G-S16 (sulphonate), G2-NF16 (naphthylsulfonated) and G3-S16 (sulphated-end groups) have potent antiviral activity against HIV-1. In this work, we evaluated the activity of these dendrimers and the fusion inhibitors T-1249 and T20 in preventing cell-free and cellassociated HIV-2 infection." | pt_PT |
dc.description.sponsorship | Fundação para a Ciência e a Tecnologia - Portugal; Fondo de Investigación Sanitaria through the Sara Borrell Program | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.26/15088 | |
dc.language.iso | eng | pt_PT |
dc.relation | Molecular epidemiology, drug resistance and pathogenesis of HIV and TB in Angola: the Angolan PErinatal HIV Cohort (APEHC) | |
dc.relation | DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NEW MICROBICIDE GEL FOR THE PREVENTION OF HIV-1 AND HIV-2 INFECTION | |
dc.subject | HIV-2 infection | pt_PT |
dc.subject | Entry inhibitors | pt_PT |
dc.subject | Carbosilane dendrimers | pt_PT |
dc.title | Entry inhibitors and Carbosilane dendrimers are potent inhibitors of cell-associated HIV-2 infection | pt_PT |
dc.type | conference object | |
dspace.entity.type | Publication | |
oaire.awardTitle | Molecular epidemiology, drug resistance and pathogenesis of HIV and TB in Angola: the Angolan PErinatal HIV Cohort (APEHC) | |
oaire.awardTitle | DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NEW MICROBICIDE GEL FOR THE PREVENTION OF HIV-1 AND HIV-2 INFECTION | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FSAU-EPI%2F122400%2F2010/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/VIH%2FSAU%2F0029%2F2011/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F89140%2F2012/PT | |
oaire.citation.conferencePlace | Banff, Alberta, Canada | pt_PT |
oaire.citation.title | 2015 Keystone Symposia Conference X5: HIV Vaccines | pt_PT |
oaire.fundingStream | 3599-PPCDT | |
oaire.fundingStream | 3599-PPCDT | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | conferenceObject | pt_PT |
relation.isProjectOfPublication | c3b60260-41c1-4212-93cd-191d5b2e6133 | |
relation.isProjectOfPublication | e63cde82-fa32-4aed-90e7-c9443427f2e1 | |
relation.isProjectOfPublication | eb28382d-1ebf-4ed8-8974-0d1d07f67887 | |
relation.isProjectOfPublication.latestForDiscovery | c3b60260-41c1-4212-93cd-191d5b2e6133 |